Vor Biopharma
Price & Volume
Stats
See more52W Range | $2.62-$65.80 |
Market Cap | $269M |
Shares Short | 22M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$273.60 |
News
See moreYahoo Finance • 12 hours ago
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • yesterday
After-Hours Movers: Biotech And Medtech Stocks Jump On Volume And News
Yahoo Finance • 5 days ago
Vor Bio Announces Late-Breaking Poster Presentation of Phase 3 Primary Sjögren’s Disease Clinical Study at ACR Convergence 2025
Yahoo Finance • 9 days ago
Vor Biopharma registers 51M shares for resale linked to RemeGen deal and PIPE financing
About
CEO | Dr. Jean-Paul Kress M.D. |
CFO | Mr. Sandesh Mahatme L.L.M. |
Address | 100 Cambridgepark Drive, Cambridge, MA, United States, 02140 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 154 |
